3 Tertiary Care Hospitals Operator, Liquid and Gas Terminals Operator and Largest FMCG Company Stocks With a Strong Future Roadmap: Global Health, Aegis Logistics and Hindustan Unilever
- November 4, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Global Health, Aegis Logistics and Hindustan Unilever: ROE of 14.1% to 22.4% and FY22 to FY26 revenue CAGR of 5.5% to 19.6%. Prices as of 3 Nov 2026.
Quick Answer
The three hospital, gas terminal and FMCG stocks to watch are Global Health, Aegis Logistics and Hindustan Unilever. Their return on equity ranges from 14.1% to 22.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.5% to 19.6%. Hindustan Unilever has the highest return on equity at 22.4%, while Global Health has the fastest revenue growth at 19.6% a year. Prices are based on the 3 November 2026 close, and this article is educational, not investment advice.
Hospital, gas terminal and FMCG stocks bring together companies with a visible plan for the years ahead. Global Health, Aegis Logistics and Hindustan Unilever cover a tertiary care hospitals operator, a liquid and gas terminals operator and the largest FMCG company.
This list covers three hospital, gas terminal and FMCG stocks with complete current figures: Global Health, Aegis Logistics and Hindustan Unilever. Every figure comes from the latest reported financials and the 3 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Hospital, Gas Terminal and FMCG Stocks?
Hospital, gas terminal and FMCG stocks are listed companies that run tertiary-care hospitals, store and handle liquid chemicals and gases at ports while distributing LPG, and sell home care, personal care, foods and beverages across India. Their earnings depend on patient volumes, port storage demand and household spending.
Hospital, Gas Terminal and FMCG Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Global Health | 1,325.8 | 33,277 | 60.3 | 59.6 | 14.1 | 0.30 |
| Aegis Logistics | 1,177.1 | 43,877 | 29.7 | 49.5 | 14.8 | 0.69 |
| Hindustan Unilever | 1,962.8 | 427,626 | 28.6 | 32.6 | 22.4 | 0.03 |
On valuation, Aegis Logistics and Hindustan Unilever trade at a P/E below the industry P/E, while Global Health trades above it, which reflects the growth the market already expects. Readers comparing hospital, gas terminal and FMCG stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Hospital, Gas Terminal and FMCG Stocks Have a Strong Roadmap in India?
Hospital, gas terminal and FMCG stocks have a strong roadmap in India because growing demand for advanced hospital care, rising gas use and broad everyday consumption keep widening the market for these companies.
- Hospitals. Complex care draws patients to large campuses.
- Terminals. Ports need storage for gas and chemicals.
- Consumer brands. Everyday products reach every town.
Why Global Health Features Among These Hospital, Gas Terminal and FMCG Stocks
Among the hospital, gas terminal and FMCG stocks on this list, Global Health, which operates the Medanta brand, runs tertiary-care hospitals led by its flagship campus in Gurugram, along with facilities in Lucknow, Patna, Ranchi, Indore and Noida.
Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%. Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%.
In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P/E of 60.3, above the industry P/E of 59.6.
Roadmap: Management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.
What to watch: Watch the ramp-up speed of newer hospitals and the pace of doctor additions at each site.
Why Aegis Logistics Features Among These Hospital, Gas Terminal and FMCG Stocks
Among the hospital, storage and consumer shares on this list, Aegis Logistics stores and handles liquid chemicals and gases at ports and also distributes liquefied petroleum gas to homes, industry and vehicles across India.
In the June 2026 quarter, revenue grew 38.2% year on year to Rs 2,463 crore. Revenue rose from Rs 4,670 crore in FY22 to Rs 8,660 crore in FY26, a compound annual growth rate of 16.7%.
Net profit grew from Rs 385 crore in FY22 to Rs 1,107 crore in FY26, which works out to a compound annual growth rate of 30.2%. The company has a return on equity of 14.8%, a debt to equity ratio of 0.69 and a market capitalisation of Rs 43,877 crore. The stock trades at a P/E of 29.7, below the industry P/E of 49.5.
Roadmap: The company is adding terminal capacity and growing its gas distribution network, which positions it for rising demand for cleaner fuels. Its port-linked storage assets are hard to replicate.
What to watch: Follow terminal capacity additions, gas volumes and new port projects.
Why Hindustan Unilever Features Among These Hospital, Gas Terminal and FMCG Stocks
Among the three companies on this list, Hindustan Unilever is India’s largest fast-moving consumer goods company, with brands across home care, beauty and personal care, foods and refreshment that reach households in every part of the country.
The company has a return on equity of 22.4%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 427,626 crore. The stock trades at a P/E of 28.6, below the industry P/E of 32.6.
Revenue rose from Rs 52,704 crore in FY22 to Rs 65,219 crore in FY26, a compound annual growth rate of 5.5%. Net profit for FY26 was Rs 10,652 crore, a net margin of 16.3%. In the June 2026 quarter, revenue grew 9.8% year on year to Rs 17,529 crore.
Roadmap: The company is premiumising its portfolio, expanding in newer categories and strengthening its rural and digital reach. A trusted brand portfolio supports steady volume growth.
What to watch: Track volume growth, rural demand and margin trends in the core categories.
Global Health vs Aegis Logistics vs Hindustan Unilever on Key Financials
The table below sets the three hospital, gas terminal and FMCG stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Global Health | 2,206 | 4,509 | 19.6% | 554 | 12.3% |
| Aegis Logistics | 4,670 | 8,660 | 16.7% | 1,107 | 12.8% |
| Hindustan Unilever | 52,704 | 65,219 | 5.5% | 10,652 | 16.3% |
Hindustan Unilever posts the highest return on equity in this group at 22.4%. Hindustan Unilever has the largest FY26 revenue at Rs 65,219 crore, and Global Health shows the fastest revenue growth with a 19.6% compound annual rate. A useful habit with hospital, gas terminal and FMCG stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Global Health | 1,051 | 1,326 | 26.1% |
| Aegis Logistics | 1,782 | 2,463 | 38.2% |
| Hindustan Unilever | 15,958 | 17,529 | 9.8% |
Key Risks to Check Before Investing in Hospital, Gas Terminal and FMCG Stocks
Every theme carries risks that deserve a check before any decision. For these hospital, gas terminal and FMCG stocks, the main points are: Long-term hospital, storage and consumer shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
- Gas prices and rules. Gas costs and regulated tariffs can influence earnings.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter hospital, gas terminal and FMCG stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Hospital, Gas Terminal and FMCG Stocks
Hospital, gas terminal and FMCG stocks suit investors who prefer to study business strength before price moves. Global Health, Aegis Logistics and Hindustan Unilever each have a clear plan to grow. Based on the 3 November 2026 close, Global Health trades at Rs 1,325.8, Aegis Logistics at Rs 1,177.1 and Hindustan Unilever at Rs 1,962.8. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these hospital, gas terminal and FMCG stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track hospital, gas terminal and FMCG stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are hospital, gas terminal and FMCG stocks?
Ans. Hospital, gas terminal and FMCG stocks are listed companies that run tertiary-care hospitals, store and handle liquid chemicals and gases at ports while distributing LPG, and sell home care, personal care, foods and beverages across India. Their earnings depend on patient volumes, port storage demand and household spending. This list looks at three of them, Global Health, Aegis Logistics and Hindustan Unilever, using reported FY22 to FY26 financials and the 3 November 2026 closing prices.
Which hospital, gas terminal and FMCG stocks are covered in this list?
Ans. This list covers Global Health, Aegis Logistics and Hindustan Unilever. Based on the 3 November 2026 close, Global Health traded at Rs 1,325.8, Aegis Logistics at Rs 1,177.1 and Hindustan Unilever at Rs 1,962.8. Their return on equity ranges from 14.1% to 22.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.5% to 19.6%.
Why do hospital, gas terminal and FMCG stocks have a strong future roadmap in India?
Ans. Hospital, gas terminal and FMCG stocks have a strong roadmap in India because growing demand for advanced hospital care, rising gas use and broad everyday consumption keep widening the market for these companies. The main drivers are as follows. Hospitals. Complex care draws patients to large campuses. Terminals. Ports need storage for gas and chemicals. Consumer brands. Everyday products reach every town. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Global Health performed financially?
Ans. Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%. Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P/E of 60.3, above the industry P/E of 59.6. Looking ahead, management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.
How has Aegis Logistics performed financially?
Ans. Revenue rose from Rs 4,670 crore in FY22 to Rs 8,660 crore in FY26, a compound annual growth rate of 16.7%. Net profit grew from Rs 385 crore in FY22 to Rs 1,107 crore in FY26, which works out to a compound annual growth rate of 30.2%. In the June 2026 quarter, revenue grew 38.2% year on year to Rs 2,463 crore. The company has a return on equity of 14.8%, a debt to equity ratio of 0.69 and a market capitalisation of Rs 43,877 crore. The stock trades at a P/E of 29.7, below the industry P/E of 49.5. Looking ahead, the company is adding terminal capacity and growing its gas distribution network, which positions it for rising demand for cleaner fuels. Its port-linked storage assets are hard to replicate.
How has Hindustan Unilever performed financially?
Ans. Revenue rose from Rs 52,704 crore in FY22 to Rs 65,219 crore in FY26, a compound annual growth rate of 5.5%. Net profit for FY26 was Rs 10,652 crore, a net margin of 16.3%. In the June 2026 quarter, revenue grew 9.8% year on year to Rs 17,529 crore. The company has a return on equity of 22.4%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 427,626 crore. The stock trades at a P/E of 28.6, below the industry P/E of 32.6. Looking ahead, the company is premiumising its portfolio, expanding in newer categories and strengthening its rural and digital reach. A trusted brand portfolio supports steady volume growth.
What risks should investors check before buying hospital, gas terminal and FMCG stocks?
Ans. Investors should check a few risks before buying hospital, gas terminal and FMCG stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Gas prices and rules. Gas costs and regulated tariffs can influence earnings. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of hospital, gas terminal and FMCG stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 3 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
